EZH2 and CD79B mutational status over time in B-cell non-Hodgkin lymphomas detected by high-throughput sequencing using minimal samples

BACKGROUND: Numerous genomic abnormalities in B-cell non-Hodgkin lymphomas (NHLs) have been revealed by novel high-throughput technologies, including recurrent mutations in EZH2 (enhancer of zeste homolog 2) and CD79B (B cell antigen receptor complex-associated protein beta chain) genes. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Saieg, Mauro Ajaj, Geddie, William R, Boerner, Scott L, Bailey, Denis, Crump, Michael, da Cunha Santos, Gilda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799012/
https://www.ncbi.nlm.nih.gov/pubmed/23361872
http://dx.doi.org/10.1002/cncy.21262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799012/
https://www.ncbi.nlm.nih.gov/pubmed/23361872
http://dx.doi.org/10.1002/cncy.21262

Ejemplares similares